GLP-1 agonists are FDA-approved medications with extensive clinical data, while 5-amino-1MQ remains a research compound
This is a game-changer for metabolic health, as research shows that this process can increase NAD+ levels in fat cells, supporting more efficient energy use and fat oxidation
How 5-Amino-1MQ Works 5-Amino-1MQ inhibits NNMT, an enzyme that converts nicotinamide (vitamin B3) to 1-methylnicotinamide (1-MNA)
5-Amino-1MQ has exhibited the ability to support mitochondrial health, potentially rejuvenating cellular energy production and mitigating age-related decline
This is why NAD+ has become one of the most-studied molecules in aging science, and why a compound that helps preserve it draws interest well beyond weight loss
Understanding these multifaceted benefits helps explain why this peptide has generated significant interest in both research and clinical settings